Email Updates

Search form

You are here

23 NOVEMBER 2018 VOLUME 19 ISSUE 47

Media Coverage

  • A lawsuit has alleged that pharmaceutical giant Gilead Sciences is “intentionally withholding” a safer drug used for HIV treatments.

    November 21, 2018
    General
    PinkNews
  • Reducing maternal viral load during pregnancy is the most important factor in preventing mother-to-child transmission (MTCT) of HIV, results of a large study published in The Pediatric Infectious Disease Journal confirm. Other risk factors for MTCT included insufficient food, a recent sexually transmitted infection (STI) and a history of diseases associated with immune suppression.

    November 21, 2018
    aidsmap
  • Influencers across YouTube, Instagram and TikTok will post an online pledge to take an HIV test before or on World AIDS Day while also nominating three of their friends to do the same. Launched by Bangkok-based Asia Pacific HIV community network APCOM and funded by the Elton John AIDS Foundation, Organizers hope the message will spread to thousands of young gay men in the region.

    November 20, 2018
    General
    Gay Star News
  • An influential panel of medical experts recommended for the first time Tuesday that physicians offer preventive medication to anyone at high risk of acquiring HIV.

    November 20, 2018
    Washington Post
  • Two cases of HIV transmission from mother to infant during the breastfeeding period when mothers had an undetectable viral load have been reported by PROMISE, a large international study of the effectiveness of antiretroviral treatment in preventing vertical HIV transmission.

    November 20, 2018
    aidsmap
  • Five companies are carrying out 63 percent of the most urgently needed global health research and development projects in the priority areas of malaria, HIV/AIDS, tuberculosis, Chagas disease, and leishmaniasis.

    November 20, 2018
    General
    Devex
  • HIV is on the decline in Switzerland, according to the latest figures of the health ministry, with only 445 new cases reported in 2017. That’s a 16 percent decrease relative to 2016.

    November 19, 2018
    General
    Swissinfo
  • HIV incidence among men-who-have-sex-with-men (MSM) and transgender women in sub-Saharan Africa is “alarmingly high,” according to research presented to the recent HIV Research for Prevention conference in Madrid. The study was conducted at sites in Kenya, Malawi and South Africa and found an overall incidence rate of 6.96 per 100 per-person years of follow-up, meaning that each year 7 percent of participants acquired a new HIV infection.

    November 19, 2018
    General
    aidsmap
  • Women living with HIV who benefitted from the support of a ‘Mama Mshauri’ reduced their risk of healthcare drop out by around one-third, reveals a study from Kenya.

    November 19, 2018
    Avert
  • Vaccines are among the world’s greatest medical advances, like clean water, soap, bleach, sewage systems and antibiotics. In a rational world — one where budgets are built on lives saved per dollar — spending on vaccine research would rival that on defense research.

    November 19, 2018
    New York Times
  • The results, published in the Journal of the International AIDS Society, show that aspirin reduced the frequency of vaginal HIV target cells by approximately 35 per cent and made them less activated.

    November 18, 2018
    General
    The Conversation
  • About 50,000 people living with HIV in Việt Nam remain unidentified.

    November 17, 2018
    General
    Viet Nam News
  • “There is still too much stigma, which is stopping so many of us from getting a simple, quick and easy test. We won’t bring an end to the Human Immunodeficiency Virus until testing is seen as completely normal and accessible for everyone,” Prince Harry said.

    November 17, 2018
    General
    Independent
  • In a new study of men who have sex with men (MSM) who were not infected with HIV, investigators found that although substance users had increased rates of sexually transmitted infections (STIs), pre-exposure prophylaxis (PrEP) adherence was not decreased by substance use.

    November 16, 2018
    Contagion Live
  • UCLA is on a mission to make the world’s most harrowing ailments—everything from bubble-baby disease to HIV—relics of the past.

    November 9, 2018
    Washington Post
  • A unique group of poz folks called post-treatment controllers are able to maintain viral suppression even during periods of treatment interruption. Although they aren’t actively taking antiretroviral medications, they remain undetectable. New research suggests how these rarities may hold the key to a functional cure.

    November 6, 2018
    HIV Plus Mag

Published Research

Announcements